Skip to content

Male synthetic sling versus Artificial urinary Sphincter Trial for men with urodynamic stress incontinence after prostate surgery

Male synthetic sling versus Artificial urinary Sphincter Trial for men with urodynamic stress incontinence after prostate surgery: Evaluation by Randomised controlled trial (MASTER)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN49212975
Enrollment
720
Registered
2013-07-22
Start date
2014-01-29
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult men with urodynamic stress incontinence after prostate surgery Urological and Genital Diseases Stress incontinence

Interventions

Two surgical operations for male urinary incontinence, a synthetic male sling and an artificial urinary sphincter (AUS) implantation will be evaluated. All adult men who have decided in discussion wit

Sponsors

North Bristol NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Adult men who have decided in discussion with their urologist to have surgery for urodynamic stress incontinence (USI) resulting from prostate surgery.

Exclusion criteria

Exclusion criteria: 1. Men who have had previous male sling or AUS surgery. 2. Men with unresolved bladder neck contracture or urethral stricture after prostate surgery. 3. Men who do not consent to be randomised (these men will be asked to consent to follow up). 4. Men with insufficient manual dexterity to operate AUS device. 5. Men who are unable to give informed consent or complete trial documentation.

Design outcomes

Primary

MeasureTime frame
1. Clinical effectiveness of implantation of the male sling compared with AUS in terms of self-reported incontinence at 12 months. 2. Cost effectiveness of a policy of primary implantation of the male sling compared with AUS, measured by incremental cost per quality-adjusted life-year (QALY) at 24 months.

Secondary

MeasureTime frame
1. Risks of each type of surgery 2. Costs of the benefits and risks of each treatment policy 3. Subsequent NHS services (including repeat surgery) needed for men with persistent or recurrent problems 4. The differential effects of the operations on other outcomes such as quality of life and general health 5. Satisfaction of the men with each procedure

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 28, 2026